Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease
Abstract Pompe disease is a metabolic myopathy due to acid alpha‐glucosidase deficiency. In addition to glycogen storage, secondary dysregulation of cellular functions, such as autophagy and oxidative stress, contributes to the disease pathophysiology. We have tested whether oxidative stress impacts...
Saved in:
Main Authors: | Antonietta Tarallo, Carla Damiano, Sandra Strollo, Nadia Minopoli, Alessia Indrieri, Elena Polishchuk, Francesca Zappa, Edoardo Nusco, Simona Fecarotta, Caterina Porto, Marcella Coletta, Roberta Iacono, Marco Moracci, Roman Polishchuk, Diego Luis Medina, Paola Imbimbo, Daria Maria Monti, Maria Antonietta De Matteis, Giancarlo Parenti |
---|---|
Format: | article |
Language: | EN |
Published: |
Wiley
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/c9d76b1dfda5478da27f60239b67fa37 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Systematic Review and Meta-Analysis of Enzyme Replacement Therapy in Late-Onset Pompe Disease
by: Alícia Dorneles Dornelles, et al.
Published: (2021) -
Molecular study of Pompe disease in Egyptian infants
by: Mona Essawi, et al.
Published: (2021) -
Importance of Timely Treatment Initiation in Infantile-Onset Pompe Disease, a Single-Centre Experience
by: Javier de las Heras, et al.
Published: (2021) -
Late-onset Pompe disease with complicated intracranial aneurysm: a Chinese case report
by: Zhang B, et al.
Published: (2016) -
AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe Disease
by: Francesca Gatto, et al.
Published: (2017)